Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Masimo Snags a New CEO
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:05pm
tags:
Masimo, Medtech, Katie Szyman
Senate sets date to vet RFK Jr.’s nomination to lead HHS
BioPharma Dive
Thursday, January 23, 2025 - 11:04pm
tags:
Senate, HHS, Robert F Kennedy Jr.
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by Skyrizi and Rinvoq spots
Fierce Pharma
Thursday, January 23, 2025 - 12:00pm
tags:
AbbVie, TV ads, DTC advertising, Skyrizi, Rinvoq
AI in medtech is taking off. Here are 4 trends to watch in 2025.
BioPharma Dive
Thursday, January 23, 2025 - 11:50am
tags:
artificial intelligence, AI, Medtech, FDA, hospitals
Merck KGaA says high asset prices call for prudent M&A approach
MSN/Reuters
Thursday, January 23, 2025 - 11:48am
tags:
Merck KGaA, Belén Garijo, M&A
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
BioSpace
Thursday, January 23, 2025 - 11:47am
tags:
AbbVie, Neomorph, molecular glue, molecular glue degraders
Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema
Clinical Trials Arena
Thursday, January 23, 2025 - 11:46am
tags:
Intellia Therapeutics, NTLA-2002, clinical trials, HAE, hereditary angiodema
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
BioSpace
Thursday, January 23, 2025 - 11:44am
tags:
Teva Pharmaceutical, black box, MS, multiple sclerosis, FDA, anaphylaxis
Maternal RSV vaccines found to cut infection risk
Axios
Thursday, January 23, 2025 - 11:42am
tags:
RSV, vaccines, Pfizer, Abrysvo, infants
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thursday, January 23, 2025 - 11:40am
tags:
Ab&B Bio-Tech, GSK, Merck, Pfizer, China, vaccines, IPOs
US/EU regulators start review of Biogen's high-dose Spinraza
Pharmaphorum
Thursday, January 23, 2025 - 11:39am
tags:
Biogen, Spinraza, SMQA
Navigating FDA’s Draft Guidance for AI-Enabled Medical Devices
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:37am
tags:
Medtech, artificial intelligence, AI-enabled devices, FDA, regulatory
RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck
NPR
Thursday, January 23, 2025 - 11:35am
tags:
Robert F Kennedy Jr., HHS, legal, Merck, Gardasil, vaccines
Biogen research team hit by layoffs as company shifts resources to external opportunities
Fierce Biotech
Wednesday, January 22, 2025 - 7:29pm
tags:
Biogen, R&D, layoffs
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wednesday, January 22, 2025 - 7:28pm
tags:
China, Takeda, Bristol Myers Squibb, IPOs, Ascentage Pharma, Sichuan Biokin Pharmaceutical, Shanghai Bao
Pulse Biosciences touts positive results from PFA early feasibility study
Clinical Trials Arena
Wednesday, January 22, 2025 - 7:26pm
tags:
Medtech, Pulse Biosciences, PFA, CellFX, atrial fibrillation
JPM25: Incyte plans to turn 'a lot of cards' in 2025 as CEO eyes 2 types of deals
Fierce Pharma
Wednesday, January 22, 2025 - 7:24pm
tags:
JPMHC 2025, Pharma CEOs, Incyte, Hervé Hoppenot
J&J joins Pfizer in detailing impact of Part D redesign
BioPharma Dive
Wednesday, January 22, 2025 - 7:23pm
tags:
JNJ, Pfizer, Medicare Part D
Calquence Combo Therapy Approved for Previously Untreated Mantle Cell Lymphoma
Hematology Advisor
Wednesday, January 22, 2025 - 7:19pm
tags:
AstraZeneca, Calquence, mantle cell lymphoma
RFK Jr. pledges to divest interests in CRISPR Tx, Dragonfly if HHS role confirmed
Fierce Biotech
Wednesday, January 22, 2025 - 7:03pm
tags:
Robert F Kennedy Jr., HHS, CRISPR Therapeutics, Dragonfly Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.